These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines. Tutonda MG; Buckheit RW; Agrawal VK; Broom AD J Med Chem; 1998 Dec; 41(25):4958-64. PubMed ID: 9836613 [TBL] [Abstract][Full Text] [Related]
4. [Antiviral properties of polynucleotides not associated with interferon induction]. Shved AD Mikrobiol Zh (1978); 1982; 44(3):75-85. PubMed ID: 6181384 [No Abstract] [Full Text] [Related]
7. [Antiviral activity of the complexes obtained at different ratios of complementary homopolyribonucleotides]. Novokhatskiĭ AS; Kogan EM; Timkovskiĭ AL Antibiotiki; 1978 May; 23(5):406-11. PubMed ID: 655685 [TBL] [Abstract][Full Text] [Related]
8. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs. Wagner A; Bock CT; Fechner H; Kurreck J Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598 [No Abstract] [Full Text] [Related]
9. Interferon induction by polynucleotides: structure-function relationship. De Clercq E Tex Rep Biol Med; 1977; 35():29-38. PubMed ID: 358456 [TBL] [Abstract][Full Text] [Related]
10. Nucleic acid-based drugs against emerging zoonotic viruses. Wong JP Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689 [TBL] [Abstract][Full Text] [Related]
11. Antiviral amphipathic oligo- and polyribonucleotides: analogue development and biological studies. Hyde RM; Broom AD; Buckheit RW J Med Chem; 2003 May; 46(10):1878-85. PubMed ID: 12723951 [TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides as antiviral agents. Agrawal S Trends Biotechnol; 1992 May; 10(5):152-8. PubMed ID: 1368317 [TBL] [Abstract][Full Text] [Related]
13. Oligonucleotides as antivirals: dream or realistic perspective? Van Aerschot A Antiviral Res; 2006 Sep; 71(2-3):307-16. PubMed ID: 16621039 [TBL] [Abstract][Full Text] [Related]
14. [Antiviral and interferonogenic activity of synthetic complexes of homopolyribonucleotides and complexes of homo- and heteropolyribonucleotides]. Vil'ner LM; Brodskaia LM; Kogan EM; Timkovskiĭ AL; Sidorova NS Vestn Akad Med Nauk SSSR; 1977; (5):64-70. PubMed ID: 196451 [No Abstract] [Full Text] [Related]
15. Short, terminally phosphorylated oligoriboguanylic acids effectively inhibit cytopathicity caused by human immunodeficiency virus. Fujihashi T; Sakata T; Kaji A; Kaji H Biochem Biophys Res Commun; 1994 Sep; 203(2):1244-50. PubMed ID: 7916572 [TBL] [Abstract][Full Text] [Related]
16. [Dependence of the antiviral activity of the poly(G).poly(C) complex on the size of the continuous poly(C)segments]. Vil'ner LM; Kogan EM; Naumovich NG; Sidorova NS; Glazunov EA Vopr Virusol; 1988; 33(3):331-5. PubMed ID: 2845672 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and properties of modified oligonucleotides. Letsinger RL; Alul RA; Farooqui F; Gryaznov SM; Kinstler O Nucleic Acids Symp Ser; 1991; (24):75-8. PubMed ID: 1841386 [TBL] [Abstract][Full Text] [Related]
18. Interferon induction in vitro by polyribonucleotides and intercalating drugs. Jamison JM; Koo PH; Tsai CC Prog Clin Biol Res; 1985; 172B():243-51. PubMed ID: 2581269 [No Abstract] [Full Text] [Related]
19. The past, present and future of antiviral drug discovery. Littler E IDrugs; 2004 Dec; 7(12):1104-12. PubMed ID: 15599804 [TBL] [Abstract][Full Text] [Related]
20. Plant and animal steroids a new hope to search for antiviral agents. Castilla V; Ramírez J; Coto CE Curr Med Chem; 2010; 17(18):1858-73. PubMed ID: 20377516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]